However, we found that, while access-related issues were a leading cause of early discontinuation, subsequent switches were frequently attributed to lack of efficacy, injection burden or AEs
Retrieved September 1 from Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF, Group SS
Demand a comprehensive and personalized approach that identifies and addresses the root causes of whatever is ailing you
Assume your tolerance has changed, even if you feel fine after your first drink
If selected for additional screening, stay calm
Cas spcifiques : Les vgtariens et vgans peuvent tre plus concerns par une supplmentation